Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-30 to 2023-01-03
Current total value of award: $2678.4
Description: 4559666564!ORALAIR 300 IR SUBLINGUAL TAB 30S